| RS2039619957 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS2039633804 |
STUB1
|
Health Risk |
Pathogenic |
— |
| RS2039634238 |
STUB1
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia 48, Spinocerebellar ataxia 48 |
| RS2039634438 |
KDM4B
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2039635021 |
GCH1
|
Health Risk |
Likely pathogenic |
— |
| RS2039641869 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2039642419 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2039643136 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2039644862 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2039651443 |
ZFYVE26
|
Health Risk |
Pathogenic/Likely pathogenic |
Spastic paraplegia, Hereditary spastic paraplegia 15 |
| RS2039654207 |
GCH1
|
Health Risk |
Pathogenic |
Dystonia 5, GTP cyclohydrolase I deficiency |
| RS2039659434 |
CEP290
|
Health Risk |
Pathogenic |
Nephronophthisis, Joubert syndrome |
| RS2039680672 |
KDM4B
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder, autosomal dominant 65 |
| RS2039682224 |
JMJD8;STUB1
|
Health Risk |
Pathogenic |
— |
| RS2039689429 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2039690812 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa 39 |
| RS2039691550 |
STUB1
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia 48, Spinocerebellar ataxia 48 |
| RS2039692173 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS2039698086 |
ETFA
|
Health Risk |
Likely pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS2039698499 |
NALCN
|
Health Risk |
Likely pathogenic |
— |
| RS2039704195 |
STUB1
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia 48, Spinocerebellar ataxia 48 |
| RS2039704361 |
STUB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Spinocerebellar ataxia 48, Spinocerebellar ataxia 48 |
| RS2039704654 |
STUB1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2039705645 |
ETFA
|
Health Risk |
Pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS2039717357 |
ETFA
|
Health Risk |
Pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS2039718061 |
ETFA
|
Health Risk |
Likely pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS2039718120 |
ETFA
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS2039720333 |
ATP8A2
|
Health Risk |
Likely pathogenic |
Cerebellar ataxia, intellectual disability |
| RS2039758874 |
ZFYVE26
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2039768709 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2039773398 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2039773989 |
ETFA
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS2039774778 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2039775751 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2039775781 |
ETFA
|
Health Risk |
Pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS2039775823 |
ETFA
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS2039777078 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2039782181 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2039786680 |
ZFYVE26
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2039789225 |
ZFYVE26
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 15, Spastic paraplegia |
| RS2039789839 |
ZFYVE26
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 15, Hereditary spastic paraplegia 15 |
| RS2039790239 |
ZFYVE26
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2039791235 |
ARMC9
|
Health Risk |
Pathogenic |
— |
| RS2039802744 |
MTM1
|
Health Risk |
Likely pathogenic |
Severe X-linked myotubular myopathy, Severe X-linked myotubular myopathy |
| RS2039803495 |
MTM1
|
Health Risk |
Pathogenic |
Severe X-linked myotubular myopathy, Severe X-linked myotubular myopathy |
| RS2039844134 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group A |
| RS2039844218 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2039844441 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS2039844868 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS2039845128 |
MTM1
|
Health Risk |
Likely pathogenic |
Severe X-linked myotubular myopathy, Severe X-linked myotubular myopathy |
| RS2039845162 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2039845956 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2039846270 |
MTM1
|
Health Risk |
Pathogenic |
Severe X-linked myotubular myopathy, Severe X-linked myotubular myopathy |
| RS2039846326 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2039866628 |
GCH1
|
Health Risk |
Pathogenic |
Dystonia 5, GTP cyclohydrolase I deficiency |
| RS2039866854 |
GCH1
|
Health Risk |
Pathogenic |
Dystonia 5, Dystonia 5 |
| RS2039877071 |
DCC
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2039894103 |
ZFYVE26
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2039897317 |
CEP290
|
Health Risk |
Likely pathogenic |
Nephronophthisis, Meckel-Gruber syndrome |
| RS2039902653 |
CEP290
|
Health Risk |
Likely pathogenic |
Nephronophthisis, Joubert syndrome |
| RS2039914110 |
HYDIN
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia 5, Primary ciliary dyskinesia 5 |
| RS2039919583 |
MTM1
|
Health Risk |
Likely pathogenic |
Severe X-linked myotubular myopathy, Severe X-linked myotubular myopathy |
| RS2039919698 |
MTM1
|
Health Risk |
Pathogenic |
Severe X-linked myotubular myopathy, Severe X-linked myotubular myopathy |
| RS2039921355 |
MTM1
|
Health Risk |
Likely pathogenic |
Severe X-linked myotubular myopathy, Severe X-linked myotubular myopathy |
| RS2039922261 |
MTM1
|
Health Risk |
Likely pathogenic |
Severe X-linked myotubular myopathy, Severe X-linked myotubular myopathy |
| RS2039933328 |
SYNJ1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 53 |
| RS2039957389 |
CIITA
|
Health Risk |
Likely pathogenic |
MHC class II deficiency, MHC class II deficiency |
| RS2039957886 |
CEP290
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2039961254 |
TRIM37
|
Health Risk |
Pathogenic |
Mulibrey nanism syndrome, Mulibrey nanism syndrome |
| RS2039966813 |
TRIM37
|
Health Risk |
Pathogenic |
— |
| RS2039977646 |
ATRIP
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2039985700 |
CEP290
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2039987359 |
CEP290
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome 14, Nephronophthisis |
| RS2039989513 |
CEP290
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2039993548 |
CEP290
|
Health Risk |
Pathogenic/Likely pathogenic |
Meckel-Gruber syndrome, Nephronophthisis |
| RS2039997721 |
ZFYVE26
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2039997846 |
ZFYVE26
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 15, Hereditary spastic paraplegia 15 |
| RS2040001177 |
ZFYVE26
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 15, Spastic paraplegia |
| RS2040001634 |
ZFYVE26
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2040007280 |
ZFYVE26
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2040024535 |
PIEZO2
|
Health Risk |
Pathogenic |
— |
| RS2040036225 |
FOXP1
|
Health Risk |
Likely pathogenic |
Intellectual disability-severe speech delay-mild dysmorphism syndrome, Intellectual disability-severe speech delay-mild dysmorphism syndrome |
| RS2040037008 |
FOXP1
|
Health Risk |
Likely pathogenic |
— |
| RS2040042896 |
OCA2
|
Health Risk |
Pathogenic |
— |
| RS2040047006 |
CEP290
|
Health Risk |
Likely pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2040056901 |
KIAA0586
|
Health Risk |
Pathogenic |
Joubert syndrome 23, Joubert syndrome 23 |
| RS2040059119 |
KIAA0586
|
Health Risk |
Pathogenic |
Short-rib thoracic dysplasia 14 with polydactyly, Joubert syndrome 23 |
| RS2040072957 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group A |
| RS2040073991 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group A |
| RS2040074214 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group A |
| RS2040076730 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2040081209 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2040082093 |
CIITA
|
Health Risk |
Pathogenic |
MHC class II deficiency, MHC class II deficiency |
| RS2040089822 |
ZFYVE26
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 15, Hereditary spastic paraplegia 15 |
| RS2040089994 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2040090240 |
ZFYVE26
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2040090741 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group A |
| RS2040090895 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Pituitary stalk interruption syndrome |
| RS2040090995 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group A |
| RS2040091615 |
ZFYVE26
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |